The light therapy market is expected to grow from US$ 930.69 million in 2022 to US$ 1,434.25 million by 2030; it is anticipated to record a CAGR of 5.6% from 2022 to 2030.

Light therapy, also known as phototherapy, is the therapeutic use of specific wavelengths of light to address a range of conditions, including dermatological disorders, mood-related disturbances, and sleep-related issues. This non-invasive treatment modality harnesses the unique properties of light to elicit biological responses within the body, often targeting the skin or retina, as well as influencing circadian rhythms and mood-regulating pathways. Light therapy can encompass various forms, such as blue light therapy for acne, red light therapy for skin rejuvenation, and bright light therapy for seasonal affective disorder.

Increasing technological advancements in light therapy drive the growth of the light therapy market.

The rapid and increasing technological advancements in light therapy have played a pivotal role in propelling the growth and dynamism of the light therapy market. These advancements have led to advanced light delivery systems with precise control over light wavelengths, intensity, and dosimetry. Integration of smart technologies, such as wearable devices and connected light therapy platforms, has enhanced accessibility and personalized treatment options while promoting adherence to prescribed light therapy protocols. Furthermore, ongoing progress in photobiomodulation research has expanded the therapeutic potential of light therapies, driving the diversification of applications and market scope. The emergence of innovative devices for circadian rhythm regulation and the development of home-use light therapy solutions have further broadened the market, making light therapy more accessible and consumer-friendly. As a result, technological advancements continue to shape the landscape of light therapy, driving innovation, accessibility, and the diversification of applications across healthcare, wellness, and consumer sectors, fostering the market's growth and expanding its adoption to cater to the evolving needs of diverse end-users.

The light therapy market is segmented based on type, light type, application, and end user. Based on type, the market is divided into benchtop and portable. The light therapy market is segmented by light type into red, blue, and white light. Based on application, the market is classified into mental health disorders, skin disorders, neonatal care, and others. The market is classified into hospitals, specialty clinics, homecare, and others based on end-user. In terms of geography, the light therapy market is divided into North America (US, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, South Africa, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).

Based on geography, the light therapy market is divided into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America is the most significant contributor to the growth of this market owing to the increasing number of people who have psoriasis and SAD/Winter blues symptoms; North America led the world market for light therapy in 2022. Under medical supervision, light treatment entails exposing the skin to UV light from artificial sources. UVB and UVA light, or a mix of the two, are used to alleviate symptoms, lessen inflammation, and limit the proliferation of skin cells. The Canadian Dermatology Association believes one million Canadians have psoriasis, driving up device demand.

The Asia Pacific light therapy market is expected to grow at the fastest CAGR from 2022 to 2030, owing to greater investments in telemedicine and greater knowledge of the advantages of light treatment. Growth is also fueled by the growing use of light therapy equipment in clinics, hospitals, and the home care market. The growing prevalence of sleep problems and the expanding use of light therapy devices in treating skin conditions like eczema, psoriasis, and acne are projected to fuel the market's growth in the upcoming years.

Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) are key primary and secondary sources referred to while preparing the drug discovery services market report.